AAVEX
Dead / Abandoned — Abandoned — failure to respond (as of 08 Apr 2024)
What this means for you
This application is over — abandoned 26 Mar 2024. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 79363339
- Mark type
- Stylized text
- Filed
- 14 Dec 2022
- Abandoned
- 26 Mar 2024
Goods and services
- Class 001 — Chemicals: Chemical and biological substances for use in science and industry; nucleic acids; nucleic recombinant acids, synthetic deoxyribonucleic acids; chemical and biological reagents for non-medical purposes; chemical and biological reagents for scientific and research purposes; human and animal cells and parts thereof for non-medical purposes; microorganisms for non-medical purposes; human and animal cells and parts thereof for scientific and research purposes; microorganisms for scientific and research purposes; viral vectors for use in science and industry; adeno-associated viruses (AAVs), AAV particles and AAV plasmids, all for scientific and research purposes
- Class 005 — Pharmaceuticals: Chemical and biological reagents for medical and veterinary use; diagnostic and test reagents for medical and veterinary use; human and animal cells and parts thereof for medical and veterinary purposes; microorganisms for medical and veterinary purposes; viral vectors for medical and veterinary purposes; adeno-associated viruses (AAVs), AAV particles and AAV plasmids, all for medical and veterinary use
- Class 042 — Scientific and technological services: Design services relating to the creation and alteration of chemical and biological reagents; design services relating to the creation and alteration of nucleic recombinant acids and synthetic deoxyribonucleic acids; design services relating to the creation and alteration of recombinant viruses; design services relating to the creation and alteration of adeno-associated viruses (AAVs), AAV particles and AAV plasmids; research, development and bioengineering services relating to adeno-associated viruses (AAVs); drug discovery services; design services relating to the creation and alteration of cell lines, elementary cells and parts thereof; design services relating to the creation and alteration of viral vectors; information and advice relating to all the aforesaid services
Owner
Prosecution history
- 26 Apr 2025 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 09 Apr 2025 — FINAL DISPOSITION NOTICE SENT TO IB
- 09 Apr 2025 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 14 Feb 2025 — NEW REPRESENTATIVE AT IB RECEIVED
- 08 Nov 2024 — NEW REPRESENTATIVE AT IB RECEIVED
- 08 Apr 2024 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 08 Apr 2024 — ABANDONMENT NOTICE MAILED - FAILURE TO RESPOND
- 08 Apr 2024 — ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
- 17 Oct 2023 — REFUSAL PROCESSED BY IB
- 25 Sept 2023 — NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
- 25 Sept 2023 — REFUSAL PROCESSED BY MPU
- 06 Sept 2023 — NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
- 05 Sept 2023 — NON-FINAL ACTION WRITTEN
- 31 Aug 2023 — ASSIGNED TO EXAMINER
- 28 Feb 2023 — APPLICATION FILING RECEIPT MAILED